Page last updated: 2024-09-03

cgp 42112a and 1-methyl-4-phenylpyridinium

cgp 42112a has been researched along with 1-methyl-4-phenylpyridinium in 1 studies

Compound Research Comparison

Studies
(cgp 42112a)
Trials
(cgp 42112a)
Recent Studies (post-2010)
(cgp 42112a)
Studies
(1-methyl-4-phenylpyridinium)
Trials
(1-methyl-4-phenylpyridinium)
Recent Studies (post-2010) (1-methyl-4-phenylpyridinium)
2330351,8541593

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiueh, CC; de Oliveira, AM; Saavedra, JM; Viswanathan, M; Wu, RM1

Other Studies

1 other study(ies) available for cgp 42112a and 1-methyl-4-phenylpyridinium

ArticleYear
[125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.
    Cellular and molecular neurobiology, 1994, Volume: 14, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding Sites; Biphenyl Compounds; Brain; Brain Injuries; Imidazoles; Iodine Radioisotopes; Losartan; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Substantia Nigra; Tetrazoles

1994